Importance B-cell–depleting therapies may affect the development of a protective immune
response following vaccination. Understanding the ability to develop vaccine-specific …

Introduction Testing for active SARS-CoV-2 infection is a fundamental tool in the public health
measures taken to control the COVID-19 pandemic. Because of the overwhelming use of …

STUDY QUESTION Does the immune response to coronavirus disease 2019 (COVID-19)
infection or the BNT162b2 mRNA vaccine involve the ovarian follicle, and does it affect its …

Zika virus (ZIKV) has emerged as a cause of congenital brain anomalies and a range of
placenta-related abnormalities, highlighting the need to unveil the modes of maternal-fetal …

Pooling multiple swab samples before RNA extraction and real-time reverse transcription
polymerase chain reaction (RT-PCR) analysis has been proposed as a strategy to reduce …

The nasal mucosa constitutes the primary entry site for respiratory viruses, including severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While the imbalanced innate …

Objective We aimed to assess the impact of early versus late third-trimester maternal severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination on transplacental …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy
and early infancy can result in severe disease. Evaluating the serologic response after …

Maternal and cord blood sera were collected from 20 parturients who received the BNT162b2
vaccine. All women and infants were positive for anti S- and anti-receptor binding domain …

Congenital cytomegalovirus (cCMV) is the most common intrauterine infection, leading to
neurodevelopmental disabilities. Universal newborn infant screening of cCMV has been …